IDG is compiling a premier microbial surveillance database, called BactNeT™. BactNeT™ is a reference metadata repository that links bacterial samples, IDG’s proprietary barcodes, and clinical information with responses to all commonly prescribed antibiotics. Sample collection is conducted in partnership with multiple national and international partners. Together with CLoNeT™, BactNeT™ forms a state-of-the art epidemiological surveillance network that brings the appropriate medicine directly to the patient’s bedside.
With its ability to respond to patient needs while simultaneously detecting global infection outbreaks, the BactNeT™ network is the first precision surveillance mechanism of its kind.
tract infections, which are at the forefront of the drug resistance crisis. A partnership with GroupHealth Research Institute in Seattle, WA has permitted early stage clinical observational trials of first-generation CLoNeT™ in the urgent care setting. These urgent-care clinical trials show that our first generation product yields results in 25-40 minutes, and reduces the rate of antibiotic prescription errors for UTIs from 1 in 4 to less than 3%. We have calculated that CLoNeT™ 2.0 will reduce error rates well below 3%. IDG’s R&D efforts have demonstrated that our proprietary ‘barcoding’ method can also be applied to other infectious pathogens.
